Vietnam successfully produces first batch of Sputnik V vaccine

On September 24, Vaccine and Biological Products Company No. 1 (Vabiotech) - a company under the Ministry of Health, officially announced the successful production of the first batch of Covid-19 vaccine Sputnik V (Gam-COVID-Vac) in Vietnam.

Dr. Do Tuan Dat, Chairman of Vabiotech, said that the unit is very pleased to announce the successful production of the first batch of Sputnik V vaccine in Vietnam. This batch of vaccine was sent to Russia on August 26 for analysis and assessment to meet the requirements of the standard. The Gamalaya National Research Institute of Epidemiology and Microbiology, Russia analyzed, assessed and assessed to meet the requirements of the standard document.

'This first batch of vaccines will help Vietnamese people soon access quality vaccines, contributing to repelling the Covid-19 epidemic' - Mr. Dat said.

According to plan, Sputnik V vaccine produced by Vabiotech will be used in the national vaccination program.

Sputnik V vaccine batch produced by Vabiotech company.

Sputnik V vaccine is developed based on the world's first registered adenovirus vector platform , the vaccination schedule is 2 doses, the interval between 2 doses is 3 weeks.

According to the results of clinical trials published in the journal 'The Lancet' , the Sputnik V vaccine was 91.6% effective. For volunteers over 60 years old, the rate was 91.8%. After vaccination, 98% of volunteers had antibodies against the SARS-CoV-2 virus.

In Vietnam, Sputnik V Vaccine was licensed for emergency use by the Ministry of Health on March 23, 2021.

On July 21, Vabiotech officially announced the trial production of Sputnik V vaccine in Vietnam.

Sputnik V vaccine is produced based on a vector technology platform that has been proven safe; Using two different vectors for two injections in one vaccination course, providing immunity for a longer period of time than vaccines that use the same delivery mechanism for both injections.